In the News

2024 AAM generic & Biosimilar Savings Report
Biosimilar Medicines Saved $12.4 Billion in 2023
September 5, 2024
Professional in a laboratory using a microscope.
Biosimilars Council Submits Comments, Applauds FDA Draft Guidance Regarding Interchangeability
August 21, 2024
Monoclonal antibodies (Adalimumab)
PBM Schemes to Control Biosimilar Humira Are Denying Patients Savings – New Analysis Shows PBM Strategies and Brand 'Product Hopping' Are Suppressing Uptake of Lower Cost Biosimilar Adalimumab
July 22, 2024
US Capitol, Build Back Better bill, BBB
Biosimilars Council Applauds Senate Passage of Cornyn-Blumenthal Patent Thicket Legislation
July 12, 2024
Biosimilars Council Submits Comments to FDA for Promotional Labeling and Advertising Considerations
June 26, 2024
Biosimilars Council Applauds Updated FDA Guidance on Interchangeability
June 21, 2024

Filter by Keyword

Filter by Audience

Filter by Category

Filter by Keyword

Filter by Issue

Filter by Category

MENU